Note: Ingredients listed on restricted chemical lists
EC/CAS
7429-90-5
Name of the chemical
Aluminium
Concentration
≥10-≤20 ≥1.0-≤5.0
EC/CAS
552-30-7
Name of the chemical
Benzene-1,2,4-tricarboxylic acid 1,2-anhydride
Concentration
<1.0
General Information
Version
1.01
Revision date
2020-02-14
Product name
HNI PR0 ANODIZED SILVER 15 BOND
1.2.1 Relevant identified uses
Industrial applications
1.2.2. Uses advised against
Coating. Paints. Painting-related materials
Manufacturer Name
PPG Industries, Inc
Emergency telephone
52 55 5559 1588, 1-888-774-2001
Icons in SDS
Company Information
company name
PPG Industries, Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H334
Hazard statements
Code
Statements
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture RESPIRATORY SENSITIZATION - Category 1 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 16.9% (Oral), 24.5% (Dermal), 90.9% (Inhalation)
Signal word
Danger
Hazard statements
H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Prevention
P284 - Wear respiratory protection. P261 - Avoid breathing dust.
Response
P304 + P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342 + P311 - If experiencing respiratory symptoms: Call a POISON CENTER or physician.
Storage
Not applicable.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Other hazards which do not result in classification
May form explosible dust-air mixture if dispersed. Handling and/or processing of this material may generate a dust which can cause mechanical irritation of the eyes, skin, nose and throat. Emits toxic fumes when heated. See toxicological information (Section 11)
2.1 Classification of the substance or mixture
RESPIRATORY SENSITIZATION - Category 1 substance or mixture Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 16.9% (Oral), 24.5% (Dermal), 90.9% (Inhalation)
